Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Clin Mol Hepatol. 2022;28(4):725-738.   Published online 2022 Mar 14     DOI: https://doi.org/10.3350/cmh.2022.0015
Citations to this article as recorded by Crossref logo
Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives
Lei Miao, Giovanni Targher, Christopher D. Byrne, Luca Valenti, Xiaolong Qi, Ming‐Hua Zheng
Portal Hypertension & Cirrhosis.2022; 1(1): 57.     CrossRef